糖尿病技术会议2023年
Tiffany Tian1, Rachel E Aaron1, Ashley Y DuNova1
1Diabetes Technology Society, Burlingame, CA, USA.
Journal of diabetes science and technology
|March 26, 2024
概括
2023年糖尿病技术会议强调了数字健康,葡萄糖监测和糖尿病管理的人工智能方面的进展. 创新包括个性化的胰岛素和碳水化合物分配器,展示了糖尿病技术的未来.
科学领域:
- 生物医学工程 生物医学工程
- 内分泌学 在内分泌学.
- 医疗信息学 医疗信息学
背景情况:
- 每年的糖尿病技术会议召集专家讨论糖尿病护理技术的最新进展.
- 数字健康和数据科学领域的不断进步正在改变糖尿病管理.
研究的目的:
- 总结了2023年糖尿病技术会议上提出的关键主题和创新.
- 突出糖尿病设备技术,数据集成和人工智能的新兴趋势.
主要方法:
- 会议涵盖了研究人员和行业领导人提出的广泛主题.
- 讨论包括数字健康工具,葡萄糖和胰岛素指标以及电子健康记录集成.
- 现场演示展示了新的糖尿病管理技术.
主要成果:
- 关注的重点领域包括连续血糖监测器,胰岛素和血糖监测技术.
- 将糖尿病数据集成到电子健康记录中是一个重要的讨论点.
- 介绍了数据科学,人工智能和用于糖尿病应用的机器学习方面的进展.
结论:
- 会议强调了糖尿病技术的快速发展,强调了个性化和数据驱动的方法.
- 未来的方向包括加强设备监管,改进药物和分析物监测,以及复杂的AI驱动的糖尿病解决方案.
- 像个性化碳水化合物分配器这样的新兴技术承诺改善患者的治疗结果.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
2.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.3K
Diabetes: Management and Pharmacotherapy
277
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
277
Diabetes Mellitus: Overview and Type I Subtype
2.6K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.6K
Diabetes: Symptoms, Diagnosis, and Complications
530
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
530
Pathophysiology of Diabetes
926
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
926
Hypoglycemia and Glucagon
257
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
257


